Evidence map›Paper›PMID 30281566›Full record

ArticlePediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies2018

Interleukin-1 Receptor Antagonist and Interleukin-1β: Risk Marker or Risk Factor for Pediatric Acute Respiratory Distress Syndrome?

Laurence Ducharme-Crevier, Jacques Lacroix

Registry-linked trialAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04153487 (Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04153487 phase2completednot on this mapstarted 2019, after this paper: background citation

Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury

TypeinterventionalSponsorDamanhour UniversityRan2019 to 2021Enrolled40ConditionsAcute Lung Injury, Transfusion RelatedArmsAscorbic Acid Injectable Product, Placebo
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Laurence Ducharme-CrevierDivision of Pediatric Critical Care, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada.
Jacques Lacroix

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Respiratory Distress SyndromeRespiratory InsufficiencyChildHumansInterleukin-1betaReceptors, Interleukin-1Risk FactorsInterleukin-1betaReceptors, Interleukin-1

Identifiers

PMID30281566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.